NeoUp2

E-health-supported assessment of psychological and somatic abnormalities, risk and resilience factors of premature infants and individualized,
interdisciplinary and multimodal Stepper-care provision

Prematurity is considered a risk factor for the development of various pathological abnormalities. Due to the wide range of developmental problems in premature babies and in order to counteract the chronification of behavioral problems, early, low-threshold and systematic identification of risk factors is essential. In Germany, there is a lack of adequate care structures for post-inpatient follow-up care.

Who is the service for
and what are its aims?

The aim of the NeoUp2 study is to investigate the feasibility and effectiveness of the web-based aftercare approach for families with a premature baby. In this context, risk and protective factors in premature babies and their parents are to be identified.

Contact

If you have any questions or are interested in participating, please contact:

E-mail address: fruehenachsorge@med.uni-tuebingen.de

Project overview (PDF)

What does the offer look like?

A randomized, controlled study design is planned over a period of 7 months (4 months treatment, 3 months follow-up). Focus groups are planned before and after the main study phase to plan and modify the study design. A total sample of 60 subjects, who are families with a preterm infant with a gestational age of 28-34 weeks, will be randomly divided into two groups and assigned to either the treatment group or the treatment as usual group. The treatment group will have access to a web application with specific written information for parents of preterm infants, the opportunity to contact the interdisciplinary study team via the web and an outpatient assessment of the parents every 14 days.